York Trials Unit, Department of Health Sciences, University of York, York YO10 5DD, UK.
Department of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK.
Nutrients. 2022 Apr 27;14(9):1817. doi: 10.3390/nu14091817.
This systematic review and meta-analysis provides a synthesis of the available evidence for the effects of interventions on outcome measures associated with sarcopenia in end-stage kidney disease (ESKD). Thirteen databases were searched, supplemented with internet and hand searching. Randomised controlled trials of non-pharmacological or pharmacological interventions in adults with ESKD were eligible. Trials were restricted to those which had reported measures of sarcopenia. Primary outcome measures were hand grip strength and sit-to-stand tests. Sixty-four trials were eligible (with nineteen being included in meta-analyses). Synthesised data indicated that intradialytic exercise increased hand grip strength (standardised mean difference, 0.58; 0.24 to 0.91; p = 0.0007; I2 = 40%), and sit-to-stand (STS) 60 score (mean difference, 3.74 repetitions; 2.35 to 5.14; p < 0.001; I2 = 0%). Intradialytic exercise alone, and protein supplementation alone, resulted in no statistically significant change in STS5 (−0.78 s; −1.86 to 0.30; p = 0.16; I2 = 0%), and STS30 (MD, 0.97 repetitions; −0.16 to 2.10; p = 0.09; I2 = 0%) performance, respectively. For secondary outcomes, L-carnitine and nandrolone-decanoate resulted in significant increases in muscle quantity in the dialysis population. Intradialytic exercise modifies measures of sarcopenia in the haemodialysis population; however, the majority of trials were low in quality. There is limited evidence for efficacious interventions in the peritoneal dialysis and transplant recipient populations.
本系统评价和荟萃分析综合了现有证据,评估了干预措施对终末期肾病(ESKD)患者与肌肉减少症相关的结局指标的影响。共检索了 13 个数据库,并辅以互联网和手工检索。纳入了 ESKD 成人患者非药物或药物干预的随机对照试验。试验仅限于报告肌肉减少症测量指标的试验。主要结局测量指标为手握力和坐站测试。有 64 项试验符合条件(其中 19 项被纳入荟萃分析)。综合数据表明,透间运动增加了手握力(标准化均数差,0.58;0.24 至 0.91;p = 0.0007;I2 = 40%)和坐站(STS)60 评分(平均差异,3.74 次;2.35 至 5.14;p < 0.001;I2 = 0%)。单独透间运动和单独蛋白质补充均未导致 STS5(-0.78 秒;-1.86 至 0.30;p = 0.16;I2 = 0%)和 STS30(MD,0.97 次;-0.16 至 2.10;p = 0.09;I2 = 0%)表现的统计学显著变化。对于次要结局,左卡尼汀和癸酸诺龙可增加透析人群的肌肉量。透间运动改变了血液透析人群肌肉减少症的测量指标;然而,大多数试验的质量较低。腹膜透析和移植受者人群中有效的干预措施证据有限。